Cirrhosis of the liver is a chronic and progressive disease in which healthy liver cells are slowly replaced by scar tissue, ...

A transjugular intrahepatic portosystemic shunt (TIPS) ... Variceal bleeding causes 15–30% of deaths among people with cirrhosis. Portal gastropathy.

Cirrhosis is one of the leading causes of mortality from non-communicable diseases, with complications arising as liver ...

Early shunt placement improved one-year outcomes in cirrhosis-related fundal variceal bleeding compared to standard therapy.

This Review considers the pathophysiologic basis for transjugular intrahepatic portosystemic shunt (TIPS) placement in cirrhotic patients with refractory ascites. The effect of TIPS placement on ...

TOPLINE: In patients with cirrhosis and acute fundal variceal bleeding, the use of preemptive transjugular intrahepatic portosystemic shunt (p-TIPS) with a covered stent within 72 hours of initial ...

TIPS is a valuable intervention for managing complications of cirrhosis, particularly in improving renal function in patients with portal hypertension. However, its role in treating HRS and HPS is ...

Cirrhosis is a condition in which scar tissue gradually replaces your healthy liver cells. It usually happens over a long period, often due to hepatitis, alcohol use disorder, or metabolic ...

Ascites is a common complication of cirrhosis but can be treated with medications, procedures, and dietary changes. ... One of the newer types of treatment is the TIPS procedure, ...

The development of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt insertion, especially within 30 days, is linked to impaired survival in patients with liver cirrhosis.